Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: Insights from the Veterans Affairs CART program

Vikas Aggarwal, Maggie A. Stanislawski, Thomas M. Maddox, Brahmajee K. Nallamothu, Gary Grunwald, Jill C. Adams, P. Michael Ho, Sunil V. Rao, Ivan P. Casserly, John S. Rumsfeld, Emmanouil S. Brilakis, Thomas T. Tsai

Research output: Contribution to journalArticle

28 Scopus citations

Abstract

Background Stenosis of saphenous vein grafts (SVGs) after coronary artery bypass grafting (CABG) is common and often requires percutaneous coronary interventions (PCI) for treatment. However, data for the effectiveness of drug-eluting stents (DES) versus bare-metal stents (BMS) in SVG-PCI are unclear. Objectives This study sought to examine the association between DES versus BMS used during SVG PCI and clinical outcomes in the national Veterans Affairs integrated healthcare system

Methods We studied a national cohort of 2,471 post-CABG veterans undergoing SVG-PCI between 2008 and 2011 at all Veterans Affairs hospitals and compared clinical outcomes of between those receiving DES and BMS. Clinical outcomes included procedural complications, myocardial infarction (MI), and all-cause mortality. Comparisons were made in a propensity-matched cohort using Cox proportional hazards regression models-absp. Results DES were used in 1,549 SVG-PCI patients (63%) and the use of DES increased progressively with each calendar year (50% in 2008 to 69% in 2011). Incidence of procedural complications was low and comparable in both groups (2.8% among BMS vs. 2.3% among DES patients; p = 0.54). During long-term (>2 years) follow-up, use of DES was associated with lower mortality than BMS (hazard ratio [HR]: 0.72; 95% confidence interval [CI]: 0.57 to 0.89) and similar rates of MI (HR: 0.94; 95% CI: 0.71 to 1.24) in the propensity-matched cohort-absp. Conclusions In a national cohort of veterans, we observed widespread and increasing use of DES during SVG-PCI. In long-term follow-up, compared with BMS, DES use was safe and effective in SVG-PCI patients.

Original languageEnglish (US)
Pages (from-to)1825-1836
Number of pages12
JournalJournal of the American College of Cardiology
Volume64
Issue number17
DOIs
StatePublished - Oct 28 2014

    Fingerprint

Keywords

  • bare-metal stent
  • drugeluting stent
  • percutaneous coronary intervention
  • repeat revascularization
  • saphenous venous graft

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Aggarwal, V., Stanislawski, M. A., Maddox, T. M., Nallamothu, B. K., Grunwald, G., Adams, J. C., Ho, P. M., Rao, S. V., Casserly, I. P., Rumsfeld, J. S., Brilakis, E. S., & Tsai, T. T. (2014). Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: Insights from the Veterans Affairs CART program. Journal of the American College of Cardiology, 64(17), 1825-1836. https://doi.org/10.1016/j.jacc.2014.06.1207